Business Context and Reporting Period
Revolution Medicines, Inc. filed a Form 8-K on August 27, 2026, reporting the entry into a material definitive agreement. The Company, a Delaware corporation headquartered in Redwood City, California, announced plans to lease four buildings at Seaport Boulevard to serve as its new headquarters.
Key Financial Metrics and Lease Terms
This filing details a significant capital commitment regarding real estate rather than operational financial performance. Key metrics include:
- Total Space: Approximately 672,000 rentable square feet across four buildings.
- Lease Term: Initial terms ending in September 2042, with options to extend for up to three additional five-year periods.
- Commencement: Staggered dates from September 26, 2027, through September 1, 2028.
- Base Rent: Approximately $2.7 million monthly at full commencement, increasing by 3% annually.
- Rent Abatement: Aggregate base rent abatement of approximately $23.1 million through January 2030.
- Tenant Improvement Allowances: Approximately $115.9 million guaranteed, with an option for an additional $40.3 million (amortized at 10% annually if used).
The filing does not provide current revenue, profit, cash flow, or debt figures for the Company.
Material Changes and Related Party Transactions
The primary material change is the execution of the new lease agreements. A significant related party transaction exists as the landlords are subsidiaries of Pacific Shores Phase II Associates, LLC, in which investment funds managed by Farallon Capital Management, L.L.C. hold a majority interest. Farallon reported beneficial ownership of approximately 6.4% of the Company's outstanding common stock as of June 30, 2026.
Outlook, Risks, and Contingencies
The effectiveness of the leases is contingent upon the "Phase II Closing," where landlords must acquire the properties. The filing outlines specific contingencies:
- Closing Deadline: If the Phase II Closing does not occur by December 31, 2026, the Company may terminate the leases. Automatic termination occurs if the closing has not occurred by April 29, 2027.
- Rent Reductions: Base rent is reduced by $0.02 per square foot if closing occurs between November 24, 2026, and December 31, 2026. If closing occurs after December 31, 2026, rent is reduced by $0.10 per square foot.
- Risks: Forward-looking statements are subject to risks including delays in the Phase II Closing, construction delays, permitting issues, cost overruns, and changes in the Company's space requirements.
Investor Verification Checklist
- Verify the status of the "Phase II Closing" to confirm if the lease agreements remain effective.
- Review the full text of the lease agreements filed as exhibits to the Form 10-Q for the quarter ending September 30, 2026.
- Assess the impact of the $115.9 million tenant improvement allowance and potential additional $40.3 million on the Company's cash flow and balance sheet.
- Monitor Farallon Capital Management's continued ownership stake and any potential conflicts of interest regarding the landlord relationship.
- Confirm the Company's ability to fund the $2.7 million monthly rent obligation upon full commencement in 2028.